Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Monofilament Suture Market by Product (Absorbable Monofilament Suture, Non-absorbable Monofilament Suture), by Application (General Surgery, Gynecological Surgery, Orthopedic Surgery, Ophthalmic Surgery, Cosmetic Plastic Surgery, Others) and by End User (Hospitals and Clinics, Surgical Centers, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11536

Pages: NA

Charts: NA

Tables: NA

Monofilament Suture Market Statistics 2028 -

A suture is a stitch made to join exposed parts of a wound. Monofilament suture is made of single strand. Because of the single-stranded design, this type of sutures is relatively more resistant to harboring pathogens. Monofilament suture further exhibits less resistance when passed through the tissue when compared to multifilament sutures. However, the healthcare provider must take great care in tying and handling monofilament sutures. This is attributed to the fact that crimping or crushing the suture can weaken or nick it. If that happens, it can lead to premature and undesirable suture failure,

Impact of COVID-19 on Medical Device Market

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Increase has been witnessed in the demand for medical supplies to take care of the infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. Furthermore, the need for medical supplies has increased among both from healthcare professionals and the civil population for precautionary measures, owing to rise in the number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the monofilament suture market.

Top Impacting Factors

The suture market is flourishing due to increase in the number of surgical procedures being performed all over the glove. The launch of advanced sutures such as monofilament sutures and favorable reimbursement scenarios for different surgical procedures further influence the monofilament suture market growth.

Adults aged 65 and above are facing a higher risk of chronic conditions and diseases. Rapid growth in this population and rise in incidence of fatal diseases are expected to influence the microfilament suture market positively.

In recent years, the number of aesthetic and cosmetic procedures has increased due to rise in disposable income, enhanced procedural safety, and the availability of advanced technologies. The popularity of these procedures will further lead to the growth of the monofilament suture market.

The normalization of the global economy after the pandemic will slowly increase surgical procedures that were kept on hold, which, in turn, will lead to market growth. However, increase in preference for minimally invasive surgeries and alternative wound care management products are some of the factors that can influence the microfilament suture market negatively.

Key Market Trends

The monofilament suture market is considerably fragmented. Key companies such as Johnson & Johnson Medical are continuing to drive innovation and adopt digital transformations. The global microfilament suture market is hence dominated by market players with niche offerings.

The shift in demand for surgical devices due to the pandemic has forced key players to focus on product development, strategize their manufacturing abilities, and provide optimum supply chain facilities across and within countries.

Players in the microfilament suture market are further altering their strategies for both short-term and long-term growth by tapping the critical care devices market and by developing innovative products during the pandemic.

Nations such as Canada, Mexico, and South America could enable fibrin sealant and adhesive companies to take advantage of potential shorter supply chains and still-open trade routes.

Key Benefits of the Report

  • This study presents the analytical depiction of the monofilament suture industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the monofilament suture market share.
  • The current market is quantitatively analyzed to highlight the monofilament suture market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed monofilament suture market analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Global Monofilament Suture Market Report

  • Which are the leading players active in the monofilament suture market?
  • How is each segment of the market expected to grow during ?
  • What are the adoption trends for monofilament suture in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is monofilament suture?
  • What is the monofilament suture market prediction in the future?
  • What are the current trends and predicted trends?

Key Market Segments

  • By Product
    • Absorbable Monofilament Suture
    • Non-absorbable Monofilament Suture
  • By Application
    • General Surgery
    • Gynecological Surgery
    • Orthopedic Surgery
    • Ophthalmic Surgery
    • Cosmetic & Plastic Surgery
    • Others
  • By End User
    • Hospitals and Clinics
    • Surgical Centers
    • Diagnostic Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Unik Surgical Sutures MFG
  • Johnson & Johnson Medical, Medtronic, Inc
  • Teleflex, Inc.
  • Lotus Surgicals
  • Kono Seisakusho
  • DemeTech, Inc.
  • Assut Medical Sarl
  • Surgical Specialties Corporation
  • AD Surgical
  • Internacional Farmacéutica
  • Peters Surgica
  • B.Braun
  • Samyang Biopharmaceuticals
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MONOFILAMENT SUTURE MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Absorbable Monofilament Suture

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Non-absorbable Monofilament Suture

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: MONOFILAMENT SUTURE MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. General Surgery

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Gynecological Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Orthopedic Surgery

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Ophthalmic Surgery

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Cosmetic And Plastic Surgery

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: MONOFILAMENT SUTURE MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals And Clinics

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Diagnostic Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: MONOFILAMENT SUTURE MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Monofilament Suture Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Monofilament Suture Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Monofilament Suture Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Monofilament Suture Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Monofilament Suture Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Monofilament Suture Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Monofilament Suture Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Monofilament Suture Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Monofilament Suture Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Monofilament Suture Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Monofilament Suture Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Monofilament Suture Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Monofilament Suture Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Monofilament Suture Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Monofilament Suture Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Monofilament Suture Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Monofilament Suture Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Monofilament Suture Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Monofilament Suture Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Monofilament Suture Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Monofilament Suture Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Monofilament Suture Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Monofilament Suture Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Monofilament Suture Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Monofilament Suture Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Johnson And Johnson Medical, Medtronic, Inc

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Peters Surgica

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. B.Braun

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Internacional Farmacéutica

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. DemeTech, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Kono Seisakusho

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Surgical Specialties Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Samyang Biopharmaceuticals

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. AD Surgical

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Unik Surgical Sutures MFG

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Assut Medical Sarl

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Teleflex, Inc.

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. Lotus Surgicals

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MONOFILAMENT SUTURE MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MONOFILAMENT SUTURE MARKET FOR ABSORBABLE MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MONOFILAMENT SUTURE MARKET FOR NON-ABSORBABLE MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MONOFILAMENT SUTURE MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MONOFILAMENT SUTURE MARKET FOR GENERAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MONOFILAMENT SUTURE MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MONOFILAMENT SUTURE MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MONOFILAMENT SUTURE MARKET FOR OPHTHALMIC SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MONOFILAMENT SUTURE MARKET FOR COSMETIC AND PLASTIC SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MONOFILAMENT SUTURE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MONOFILAMENT SUTURE MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MONOFILAMENT SUTURE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MONOFILAMENT SUTURE MARKET FOR SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MONOFILAMENT SUTURE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL MONOFILAMENT SUTURE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL MONOFILAMENT SUTURE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. U.S. MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. U.S. MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. CANADA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. CANADA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. CANADA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. ITALY MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. ITALY MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. ITALY MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. UK MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. UK MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. UK MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. CHINA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. CHINA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. CHINA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. INDIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. INDIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. INDIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MONOFILAMENT SUTURE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. UAE MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. UAE MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. UAE MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA MONOFILAMENT SUTURE, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA MONOFILAMENT SUTURE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA MONOFILAMENT SUTURE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: KEY EXECUTIVES
  • TABLE 109. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: COMPANY SNAPSHOT
  • TABLE 110. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: OPERATING SEGMENTS
  • TABLE 111. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: PRODUCT PORTFOLIO
  • TABLE 112. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. PETERS SURGICA: KEY EXECUTIVES
  • TABLE 114. PETERS SURGICA: COMPANY SNAPSHOT
  • TABLE 115. PETERS SURGICA: OPERATING SEGMENTS
  • TABLE 116. PETERS SURGICA: PRODUCT PORTFOLIO
  • TABLE 117. PETERS SURGICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. B.BRAUN: KEY EXECUTIVES
  • TABLE 119. B.BRAUN: COMPANY SNAPSHOT
  • TABLE 120. B.BRAUN: OPERATING SEGMENTS
  • TABLE 121. B.BRAUN: PRODUCT PORTFOLIO
  • TABLE 122. B.BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. INTERNACIONAL FARMACéUTICA: KEY EXECUTIVES
  • TABLE 124. INTERNACIONAL FARMACéUTICA: COMPANY SNAPSHOT
  • TABLE 125. INTERNACIONAL FARMACéUTICA: OPERATING SEGMENTS
  • TABLE 126. INTERNACIONAL FARMACéUTICA: PRODUCT PORTFOLIO
  • TABLE 127. INTERNACIONAL FARMACéUTICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. DEMETECH, INC.: KEY EXECUTIVES
  • TABLE 129. DEMETECH, INC.: COMPANY SNAPSHOT
  • TABLE 130. DEMETECH, INC.: OPERATING SEGMENTS
  • TABLE 131. DEMETECH, INC.: PRODUCT PORTFOLIO
  • TABLE 132. DEMETECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. KONO SEISAKUSHO: KEY EXECUTIVES
  • TABLE 134. KONO SEISAKUSHO: COMPANY SNAPSHOT
  • TABLE 135. KONO SEISAKUSHO: OPERATING SEGMENTS
  • TABLE 136. KONO SEISAKUSHO: PRODUCT PORTFOLIO
  • TABLE 137. KONO SEISAKUSHO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. SURGICAL SPECIALTIES CORPORATION: KEY EXECUTIVES
  • TABLE 139. SURGICAL SPECIALTIES CORPORATION: COMPANY SNAPSHOT
  • TABLE 140. SURGICAL SPECIALTIES CORPORATION: OPERATING SEGMENTS
  • TABLE 141. SURGICAL SPECIALTIES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 142. SURGICAL SPECIALTIES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. SAMYANG BIOPHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 144. SAMYANG BIOPHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 145. SAMYANG BIOPHARMACEUTICALS: OPERATING SEGMENTS
  • TABLE 146. SAMYANG BIOPHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 147. SAMYANG BIOPHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. AD SURGICAL: KEY EXECUTIVES
  • TABLE 149. AD SURGICAL: COMPANY SNAPSHOT
  • TABLE 150. AD SURGICAL: OPERATING SEGMENTS
  • TABLE 151. AD SURGICAL: PRODUCT PORTFOLIO
  • TABLE 152. AD SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. UNIK SURGICAL SUTURES MFG: KEY EXECUTIVES
  • TABLE 154. UNIK SURGICAL SUTURES MFG: COMPANY SNAPSHOT
  • TABLE 155. UNIK SURGICAL SUTURES MFG: OPERATING SEGMENTS
  • TABLE 156. UNIK SURGICAL SUTURES MFG: PRODUCT PORTFOLIO
  • TABLE 157. UNIK SURGICAL SUTURES MFG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. ASSUT MEDICAL SARL: KEY EXECUTIVES
  • TABLE 159. ASSUT MEDICAL SARL: COMPANY SNAPSHOT
  • TABLE 160. ASSUT MEDICAL SARL: OPERATING SEGMENTS
  • TABLE 161. ASSUT MEDICAL SARL: PRODUCT PORTFOLIO
  • TABLE 162. ASSUT MEDICAL SARL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. TELEFLEX, INC.: KEY EXECUTIVES
  • TABLE 164. TELEFLEX, INC.: COMPANY SNAPSHOT
  • TABLE 165. TELEFLEX, INC.: OPERATING SEGMENTS
  • TABLE 166. TELEFLEX, INC.: PRODUCT PORTFOLIO
  • TABLE 167. TELEFLEX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168. LOTUS SURGICALS: KEY EXECUTIVES
  • TABLE 169. LOTUS SURGICALS: COMPANY SNAPSHOT
  • TABLE 170. LOTUS SURGICALS: OPERATING SEGMENTS
  • TABLE 171. LOTUS SURGICALS: PRODUCT PORTFOLIO
  • TABLE 172. LOTUS SURGICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MONOFILAMENT SUTURE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MONOFILAMENT SUTURE MARKET
  • FIGURE 3. SEGMENTATION MONOFILAMENT SUTURE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MONOFILAMENT SUTURE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMONOFILAMENT SUTURE MARKET
  • FIGURE 11. MONOFILAMENT SUTURE MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. MONOFILAMENT SUTURE MARKET FOR ABSORBABLE MONOFILAMENT SUTURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MONOFILAMENT SUTURE MARKET FOR NON-ABSORBABLE MONOFILAMENT SUTURE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MONOFILAMENT SUTURE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. MONOFILAMENT SUTURE MARKET FOR GENERAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MONOFILAMENT SUTURE MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MONOFILAMENT SUTURE MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MONOFILAMENT SUTURE MARKET FOR OPHTHALMIC SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MONOFILAMENT SUTURE MARKET FOR COSMETIC AND PLASTIC SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MONOFILAMENT SUTURE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MONOFILAMENT SUTURE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. MONOFILAMENT SUTURE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. MONOFILAMENT SUTURE MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. MONOFILAMENT SUTURE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. MONOFILAMENT SUTURE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: MONOFILAMENT SUTURE MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. JOHNSON AND JOHNSON MEDICAL, MEDTRONIC, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. PETERS SURGICA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. PETERS SURGICA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. PETERS SURGICA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. B.BRAUN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. B.BRAUN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. B.BRAUN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. INTERNACIONAL FARMACéUTICA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. INTERNACIONAL FARMACéUTICA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. INTERNACIONAL FARMACéUTICA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. DEMETECH, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. DEMETECH, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. DEMETECH, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. KONO SEISAKUSHO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. KONO SEISAKUSHO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. KONO SEISAKUSHO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. SURGICAL SPECIALTIES CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. SURGICAL SPECIALTIES CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. SURGICAL SPECIALTIES CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. SAMYANG BIOPHARMACEUTICALS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. SAMYANG BIOPHARMACEUTICALS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. SAMYANG BIOPHARMACEUTICALS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. AD SURGICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. AD SURGICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. AD SURGICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. UNIK SURGICAL SUTURES MFG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. UNIK SURGICAL SUTURES MFG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. UNIK SURGICAL SUTURES MFG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 63. ASSUT MEDICAL SARL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 64. ASSUT MEDICAL SARL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 65. ASSUT MEDICAL SARL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 66. TELEFLEX, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 67. TELEFLEX, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 68. TELEFLEX, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 69. LOTUS SURGICALS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 70. LOTUS SURGICALS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 71. LOTUS SURGICALS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Monofilament Suture Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue